0001104659-22-072369.txt : 20220617
0001104659-22-072369.hdr.sgml : 20220617
20220617160133
ACCESSION NUMBER: 0001104659-22-072369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Thomas A
CENTRAL INDEX KEY: 0001854168
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40363
FILM NUMBER: 221023669
MAIL ADDRESS:
STREET 1: C/O TRANSCODE THERAPEUTICS, INC.
STREET 2: 6 LIBERTY SQUARE, #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcode Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829635
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811065054
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-301-6857
MAIL ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
tm2218778-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-16
0
0001829635
Transcode Therapeutics, Inc.
RNAZ
0001854168
Fitzgerald Thomas A
C/O TRANSCODE THERAPEUTICS, INC.
6 LIBERTY SQUARE, #2382
BOSTON
MA
02109
1
1
0
0
Chief Financial Officer
Common Stock
2022-06-16
4
P
0
12000
1.27
A
139377
D
/s/ Thomas A. Fitzgerald
2022-06-17